AGP Picks
View all

Massachusetts Weekly
Provided by AGP

Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 14, 2026

Topo Athletic Expands the Pro Series with the New Specter Elite
Jul. 14, 2026

Topo Athletic Expands the Pro Series with the New Specter Elite

Indeterminate EIN Presswire
MotivationMetrics Launches Emotional Needs Scoring for Consumer Data in Prosper Model Factory
Jul. 14, 2026

MotivationMetrics Launches Emotional Needs Scoring for Consumer Data in Prosper Model Factory

Indeterminate EIN Presswire
Influential Women Showcases Alexandria Hunter-Whalen: Speaker Empowering Leaders Through Executive Presence
Jul. 14, 2026

Influential Women Showcases Alexandria Hunter-Whalen: Speaker Empowering Leaders Through Executive Presence

Indeterminate EIN Presswire
RealCISO Launches Continuous GRC & Compliance: 300+ Automated Checks Across Cloud, Identity, and Productivity Platforms
Jul. 14, 2026

RealCISO Launches Continuous GRC & Compliance: 300+ Automated Checks Across Cloud, Identity, and Productivity Platforms

Indeterminate EIN Presswire
LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
Jul. 14, 2026

LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026

Indeterminate GlobeNewswire
Rapid7 to Report Second Quarter 2026 Financial Results on August 10
Jul. 14, 2026

Rapid7 to Report Second Quarter 2026 Financial Results on August 10

Indeterminate GlobeNewswire
LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment
Jul. 14, 2026

LEQEMBI® Real-World LEADER Study Presented at AAIC® 2026 Finds Over 75% of Early Alzheimer’s Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment

Indeterminate GlobeNewswire
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
Jul. 14, 2026

Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease

Indeterminate GlobeNewswire
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
Jul. 14, 2026

Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026

Indeterminate GlobeNewswire
Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress
Jul. 14, 2026

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
Jul. 14, 2026

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire
Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
Jul. 14, 2026

Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody

Indeterminate GlobeNewswire

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.